Pharmaceutical compositions comprising an anti-teratogenic compound and applications of the same
First Claim
Patent Images
1. A method of inhibiting the teratogenicity of an anti-neoplastic agent, the method comprising administering a pharmaceutical composition comprising Noggin.
3 Assignments
0 Petitions
Accused Products
Abstract
Pharmaceutical compositions comprising anti-teratogenic agents are disclosed. Additionally, pharmaceutical compositions comprising anti-neoplastic agents and anti-teratogenic agents are disclosed. Methods of assessing the teratogenicity of a compound are disclosed. The present invention further comprises applications of the aforementioned compositions and methods.
13 Citations
8 Claims
- 1. A method of inhibiting the teratogenicity of an anti-neoplastic agent, the method comprising administering a pharmaceutical composition comprising Noggin.
- 2. A method of inhibiting the teratogenicity of an anti-neoplastic agent, the method comprising administering a pharmaceutical composition comprising an anti-Dkk1 antibody.
- 3. A method of inhibiting the teratogenicity of an anti-neoplastic agent, the method comprising administering a pharmaceutical composition comprising LiCl or Gsk3-Inhibitor IX.
Specification